𝔖 Bobbio Scriptorium
✦   LIBER   ✦

9168 Safety and efficacy of first-line bevacizumab-based therapy in advanced non-small cell lung cancer (NSCLC): results of the SAiL study (MO19390)

✍ Scribed by Dansin, E.; Tsai, C.M.; Pavlakis, N.; Laskin, J.; Griesinger, F.; Garrido, P.; Crino, L.; Wu, Y.L.; Jiang, G.L.; Thatcher, N.


Book ID
122340425
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
48 KB
Volume
7
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES